Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 2
2013 3
2014 1
2019 1
2020 3
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
Prager GW, Taieb J, Fakih M, Ciardiello F, Van Cutsem E, Elez E, Cruz FM, Wyrwicz L, Stroyakovskiy D, Pápai Z, Poureau PG, Liposits G, Cremolini C, Bondarenko I, Modest DP, Benhadji KA, Amellal N, Leger C, Vidot L, Tabernero J; SUNLIGHT Investigators. Prager GW, et al. N Engl J Med. 2023 May 4;388(18):1657-1667. doi: 10.1056/NEJMoa2214963. N Engl J Med. 2023. PMID: 37133585 Clinical Trial.
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.
Agnelli G, Becattini C, Meyer G, Muñoz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M; Caravaggio Investigators. Agnelli G, et al. N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Epub 2020 Mar 29. N Engl J Med. 2020. PMID: 32223112 Clinical Trial.
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A, Brenner B, Kakkar A, Rafii H, Solymoss S, Brilhante D, Monreal M, Bounameaux H, Pabinger I, Douketis J; International Initiative on Thrombosis and Cancer (ITAC) advisory panel. Farge D, et al. Lancet Oncol. 2019 Oct;20(10):e566-e581. doi: 10.1016/S1470-2045(19)30336-5. Epub 2019 Sep 3. Lancet Oncol. 2019. PMID: 31492632
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.
Bennouna J, Sastre J, Arnold D, Österlund P, Greil R, Van Cutsem E, von Moos R, Viéitez JM, Bouché O, Borg C, Steffens CC, Alonso-Orduña V, Schlichting C, Reyes-Rivera I, Bendahmane B, André T, Kubicka S; ML18147 Study Investigators. Bennouna J, et al. Lancet Oncol. 2013 Jan;14(1):29-37. doi: 10.1016/S1470-2045(12)70477-1. Epub 2012 Nov 16. Lancet Oncol. 2013. PMID: 23168366 Clinical Trial.
SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019).
Muñoz Martín AJ, Gallardo Díaz E, García Escobar I, Macías Montero R, Martínez-Marín V, Pachón Olmos V, Pérez Segura P, Quintanar Verdúguez T, Salgado Fernández M. Muñoz Martín AJ, et al. Among authors: pachon olmos v. Clin Transl Oncol. 2020 Feb;22(2):171-186. doi: 10.1007/s12094-019-02263-z. Epub 2020 Jan 24. Clin Transl Oncol. 2020. PMID: 31981080
Initial Single-center Experience of PIPAC in Patients With Unresectable Peritoneal Metastasis.
Cuadrado Ayuso M, Cabañas Montero J, Priego Jiménez P, Corral Moreno S, Longo Muñoz F, Pachón Olmos V, Fernández Cebrián JM, Galindo Álvarez J. Cuadrado Ayuso M, et al. Among authors: pachon olmos v. Cir Esp (Engl Ed). 2021 May;99(5):354-360. doi: 10.1016/j.ciresp.2020.06.020. Epub 2020 Aug 3. Cir Esp (Engl Ed). 2021. PMID: 32762956 English, Spanish.
Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial.
Carmona-Bayonas A, Verso M, Sánchez Cánovas M, Rubio Pérez J, García de Herreros M, Martínez Del Prado P, Fernández Pérez I, Quintanar Verduguez T, Obispo Portero B, Pachón Olmos V, Gómez D, Ortega L, Serrano Moyano M, M Brozos E, Biosca M, Antonio Rebollo M, Teijeira Sanchez L, Hernández Pérez C, David Cumplido Burón J, Martínez Lago N, García Pérez E, Muñoz Langa J, Pérez Segura P, Martínez de Castro E, Jimenez-Fonseca P, Agnelli G, Muñoz A. Carmona-Bayonas A, et al. Among authors: pachon olmos v. Thromb Haemost. 2022 Oct;122(10):1653-1661. doi: 10.1055/a-1816-8347. Epub 2022 Apr 5. Thromb Haemost. 2022. PMID: 35381615 Free PMC article.
Multiple vertebral metastases with fluid-fluid levels.
Sifuentes Giraldo WA, Pachón Olmos V, Gallego Rivera JI, Vázquez Díaz M. Sifuentes Giraldo WA, et al. Among authors: pachon olmos v. Reumatol Clin. 2014 Sep-Oct;10(5):338-9. doi: 10.1016/j.reuma.2013.10.003. Epub 2013 Nov 26. Reumatol Clin. 2014. PMID: 24286932 Free article. No abstract available.
Spanish Society of Medical Oncology (SEOM) Cancer and Thrombosis Working Group.
Muñoz Martín AJ, Pachón Olmos V, Martín Jiménez M, Alba Conejo E, Cruz Hernández JJ; SEOM Cancer and Thrombosis Working Group. Muñoz Martín AJ, et al. Among authors: pachon olmos v. Clin Transl Oncol. 2012 Feb;14(2):160. doi: 10.1007/s12094-012-0777-3. Clin Transl Oncol. 2012. PMID: 22301407 No abstract available.
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings.
Kubicka S, Greil R, André T, Bennouna J, Sastre J, Van Cutsem E, von Moos R, Osterlund P, Reyes-Rivera I, Müller T, Makrutzki M, Arnold D; ML18147 study investigators including AIO, GERCOR, FFCD, UNICANCER GI, TTD, BGDO, GEMCAD, and AGMT groups. Kubicka S, et al. Ann Oncol. 2013 Sep;24(9):2342-9. doi: 10.1093/annonc/mdt231. Epub 2013 Jul 12. Ann Oncol. 2013. PMID: 23852309 Free article. Clinical Trial.
11 results